Last updated 33 days ago

A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

15500 patients around the world
Available in United States, Chile
Janssen Research & Development, LLC
15500Patients around the world
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy